Form 4 for CABA Cabaletta Bio, Inc.
Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0000899243-22-004158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-02 | 2022-01-31 | CABA | Nichtberger Steven | Pres, CEO, Dir | M - OptEx | $1.01 | +50.0K | 836.5K | +6% | +$50.5K |
| D | 2022-02-02 | 2022-01-31 | CABA | Nichtberger Steven | Pres, CEO, Dir | M - OptEx | $0.00 | -50.0K | 229.7K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-31 | M | A | 50,000 | $1.01 | 836,483 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-31 | M | D | 50,000 | $0.00 | 229,677 | D | $1.01 · — to 2028-10-28 | 50,000 Common Stock | (F2) On October 29, 2018, the reporting person was granted a stock option to purchase 279,677 shares of common stock. The shares vest and become exercisable over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 36 equal monthly installments thereafter. On January 31, 2022 the reporting person exercised this option for 50,000 shares. |